← SynDRA
PF-06273340
SynDRA canonical compound SYN0039332 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | NTRK1 | NTRK2 | NTRK3 |
| Mechanism of action | tyrosine kinase receptor inhibitor |
All known targets
Mechanisms of action (all sources)
- tyrosine kinase receptor inhibitor
Cross-references
Synonyms
- PF06273340
- I136775ABW
- RefChem:172248
- C23H22ClN7O3
- UNII-I136775ABW
- orb1706029
- SCHEMBL12984736
- SCHEMBL29794809
- SCHEMBL30274647
- CGC43874
- EX-A2868
- BDBM50550246
- MFCD28902308
- s8407
- AKOS030211018
- AT14672
- CCG-269543
- EBC-221082
- SB18707
- NCGC00506868-03
- DA-66603
- TS-08066
- HY-122616
- CS-0087536
- T19649
- PF-06273340, >=98% (HPLC)
- 6K4
Look up PF-06273340 in the interactive SynDRA portal →